SCHEMBL20154101

SCHEMBL20154101

Cc1nccn1-c1nc(Cl)c(Cl)c(N2CCOCC2)n1

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 4/20 0.53
MTOR P42345 3/20 0.53
NPSR1 Q6W5P4 1/20 0.44
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 1/20 0.37
PDE10A Q9Y233 2/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
TSHR P16473 1/20 0.36
PIK3R1 P27986 1/20 0.36
LRRK2 Q5S007 1/20 0.36
JAK2 O60674 1/20 0.36
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20154103 0.82 MTOR (0.49) PIK3CAMTOR
SCHEMBL4018233 0.81 PIK3CA (0.65) PIK3CAMTORNPSR1MAPK1LMNA
SCHEMBL20154108 0.77 KMT2A (0.43) PIK3CAMTORNPSR1ALDH1A1MAPK1
SCHEMBL20154109 0.72 NPSR1 (0.49) NPSR1KDM4EALDH1A1MAPK1LMNA
SCHEMBL8012871 0.72 PIK3CA (0.79) PIK3CAMTORNPSR1ALDH1A1PDE10A
SCHEMBL10904452 0.71 ALDH1A1 (0.53) PIK3CAMTORKDM4EALDH1A1MAPK1
SCHEMBL1311534 0.71 PIK3CA (0.61) PIK3CAMTORNPSR1PIK3R1
SCHEMBL28435645 0.70 ALDH1A1 (0.39) PIK3CAMTORKDM4EALDH1A1LMNA
SCHEMBL16036853 0.69 PIK3R1 (0.48) PIK3CANPSR1KDM4EALDH1A1MAPK1
SCHEMBL8008565 0.69 PIK3CA (1.00) PIK3CAMTORPIK3R1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538523-B1 PYRIMIDINONE DERIVATIVES AS CDC7 INHIBITORS CANCER RESEARCH TECH LTD (GB) 2021-05-19 EP disclosed
WO-2018087527-A1 PYRIMIDINONE DERIVATIVES AS CDC7 INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2018-05-17 WO disclosed